Affluent Medical appoints Liane Teplitsky as a new member of the Board of Directors
Read the press...
10th successful human implantation of Artus urinary sphincter, marking completion of the pilot phase
Read the press...
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO
See the...
Interview with Dr. Sarraf
Epygon: A unique device for mitral valve repair
Voir la...
Interview with Michel Therin, Chairman of the Board of Directors and Sébastien Ladet, CEO, in the “Actu Bourse” issue on Boursorama
12 September 2024 Voir la...
Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
12 july 2024 See...
Successful first-in-human implantation of artificial sphincter Artus for the treatment of stress urinary incontinence
12 March 2024 See...
PCR London Valves – Conference, London
19 -21 November 2023 Learn...
Recent Comments